blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3169406

EP3169406 - POLYMERIC ENKEPHALIN PRODRUGS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.05.2021
Database last updated on 19.10.2024
FormerExamination is in progress
Status updated on  09.10.2020
FormerRequest for examination was made
Status updated on  21.04.2017
FormerThe international publication has been made
Status updated on  13.01.2017
Most recent event   Tooltip28.05.2021Application deemed to be withdrawnpublished on 30.06.2021  [2021/26]
Applicant(s)For all designated states
PEG Biosciences, Inc.
11 Deer Park Drive, Suite 102C
Monmouth Junction, NJ 08852 / US
[2017/21]
Inventor(s)01 / LEE, Chyi
9 Landing Lane
Princeton Junction, NJ 08850 / US
 [2017/21]
Representative(s)Zacco GmbH
Bayerstrasse 83
80335 München / DE
[2017/21]
Application number, filing date15821328.014.07.2015
[2017/21]
WO2015US40387
Priority number, dateUS201462024116P14.07.2014         Original published format: US 201462024116 P
[2017/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016011037
Date:21.01.2016
Language:EN
[2016/03]
Type: A1 Application with search report 
No.:EP3169406
Date:24.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 21.01.2016 takes the place of the publication of the European patent application.
[2017/21]
Search report(s)International search report - published on:US21.01.2016
(Supplementary) European search report - dispatched on:EP13.12.2017
ClassificationIPC:A61P25/00, C08G65/333, A61K47/50, C08G65/332, A61K38/33, C07K14/70, A61K47/60
[2018/02]
CPC:
A61K38/33 (EP,US); A61K47/60 (EP,US); A61P25/00 (EP);
A61P43/00 (EP); C07K14/70 (EP,US); C08G65/332 (EP,US);
C08G65/333 (EP,US); A61K47/50 (EP,US); C08L2203/02 (EP,US) (-)
Former IPC [2017/21]A61P25/00, C08G65/333, A61K47/50
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/21]
TitleGerman:POLYMERE ENKEPHALIN-PRODRUGS[2017/21]
English:POLYMERIC ENKEPHALIN PRODRUGS[2017/21]
French:PROMÉDICAMENTS D'ENKÉPHALINE POLYMÈRES[2017/21]
Entry into regional phase13.01.2017National basic fee paid 
13.01.2017Search fee paid 
13.01.2017Designation fee(s) paid 
13.01.2017Examination fee paid 
Examination procedure13.01.2017Examination requested  [2017/21]
13.01.2017Date on which the examining division has become responsible
18.07.2018Amendment by applicant (claims and/or description)
08.10.2020Despatch of a communication from the examining division (Time limit: M04)
02.02.2021Application deemed to be withdrawn, date of legal effect  [2021/26]
24.02.2021Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2021/26]
Fees paidRenewal fee
27.07.2017Renewal fee patent year 03
24.07.2018Renewal fee patent year 04
30.07.2019Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.07.202006   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US3960830  (BAYER ERNST, et al) [X] 8-11,13,14 * example 3 * * examples 1-6 * * claims 1-2 *[Y] 12;
 [X]WO0009073  (PROTEIN DELIVERY INC [US], et al) [X] 1-3,8,9 * figure 10 * * examples 5.3-5.5 * * claims 1-72 *;
 [XYI]US2011171165  (FRY DENNIS G [US], et al) [X] 9 * paragraph [[0285]] - paragraph [[0286]] * * paragraph [[0006]] - paragraph [[0008]] * * paragraph [[0189]] - paragraph [[0190]] * * examples OGF1-OGF6 * * paragraph [[0204]] - paragraph [[0206]] * * paragraph [[0286]] * * paragraph [[0094]] * * paragraph [[0077]] * [Y] 12 [I] 1-8,10,11,13,15;
 [X]CN102250251  (UNIV HEBEI NORMAL) [X] 9,10 * tables 1-4 * * abstract *
International search[Y]US2011144065  (DENARDO SALLY J [US], et al) [Y] 4, 6* para [0067], [0068] *;
 [XY]US2011171165  (FRY DENNIS G [US], et al) [X] 1-3, 5, 7-9, 12-16 * para [0002], [0003], [0010]-[0024], [0032], [0033], [0072], [0077], [0094], [0128], [0135], [0190], [0204], [0205], [0272], [0285], [0286], [0290], [0296], [0297] * [Y] 4, 6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.